Ralexar Therapeutics Overview
- Year Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
2ndary - Private
- Investors
-
1
Ralexar Therapeutics General Information
Description
Developer of topical and systemic therapies designed to treat various dermatological conditions. The company's therapies are based on liver X receptor modulators for the treatment of different cutaneous inflammatory disorders, including atopic dermatitis, enabling patients to begin treatment early and resulting in a higher likelihood of successful treatment.
Contact Information
Website
www.ralexar.comCorporate Office
- 640 Lee Road
- Suite 118
- Wayne, PA 19087
- United States
Corporate Office
- 640 Lee Road
- Suite 118
- Wayne, PA 19087
- United States
Ralexar Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Secondary Transaction - Private | 01-Apr-2026 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 25-Mar-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 06-Jun-2017 | Completed | Startup | |||
| 2. Grant | 23-Jan-2015 | $21.5M | Completed | Startup | ||
| 1. Early Stage VC (Series A) | 02-Jan-2014 | $21.5M | $21.5M | Completed | Startup |
Ralexar Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A2 | ||||||||
| Series A1 | 8,600,000 | $0.000100 | 7% | $1 | $1 | 1x | $1 | 21.93% |
Ralexar Therapeutics Comparisons
Industry
Financing
Details
Ralexar Therapeutics Competitors (86)
One of Ralexar Therapeutics’s 86 competitors is Voyager Therapeutics, a Formerly VC-backed company based in Lexington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Voyager Therapeutics | Formerly VC-backed | Lexington, MA | ||||
| BioCardia | Formerly VC-backed | Sunnyvale, CA | ||||
| Enterome | Venture Capital-Backed | Paris, France | ||||
| Mighty Therapeutics | Private Equity-Backed | Needham, MA | ||||
| Vertex Pharmaceuticals | Formerly VC-backed | Boston, MA |
Ralexar Therapeutics Patents
Ralexar Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2014315206-A1 | Liver x receptor (lxr) modulators | Inactive | 04-Sep-2013 | ||
| EP-3041834-A1 | Liver x receptor (lxr) modulators | Inactive | 04-Sep-2013 | ||
| EP-3041834-A4 | Liver x receptor (lxr) modulators | Inactive | 04-Sep-2013 | ||
| US-10246419-B2 | Liver x receptor (lxr) modulators | Active | 04-Sep-2013 | ||
| US-20160214943-A1 | Liver x receptor (lxr) modulators | Active | 04-Sep-2013 | C07D231/12 |
Ralexar Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| NeXeption | Corporation | Minority |
Ralexar Therapeutics FAQs
-
When was Ralexar Therapeutics founded?
Ralexar Therapeutics was founded in 2014.
-
Where is Ralexar Therapeutics headquartered?
Ralexar Therapeutics is headquartered in Wayne, PA.
-
What industry is Ralexar Therapeutics in?
Ralexar Therapeutics’s primary industry is Drug Discovery.
-
Is Ralexar Therapeutics a private or public company?
Ralexar Therapeutics is a Private company.
-
What is Ralexar Therapeutics’s current revenue?
The current revenue for Ralexar Therapeutics is .
-
How much funding has Ralexar Therapeutics raised over time?
Ralexar Therapeutics has raised $29.9M.
-
Who are Ralexar Therapeutics’s investors?
NeXeption has invested in Ralexar Therapeutics.
-
Who are Ralexar Therapeutics’s competitors?
Voyager Therapeutics, BioCardia, Enterome, Mighty Therapeutics, and Vertex Pharmaceuticals are some of the 86 competitors of Ralexar Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process